← Leaderboards
Steven C. Borkan
Boston Medical Center
$7,441,803
Attributed
$7,558,393
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $704.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,558,393 · 3
By mechanism
R01$7,325,213 · 2
T32$233,180 · 1
Top collaborators
- Vickery E Trinkaus-Randall1 shared
Most similar at Boston Medical Center
Same institution · by research overlap
- Ian R Rifkin$6,726,554
- Jonathan Michael Gall$127,710
- Richard Goldstein$2,188,221
Others in their field
Top investigators on “Molecular Chaperones”
- Scott J Hultgren · Washington University$24,111,975
- Judith Frydman · Stanford University$23,842,034
- Wah Chiu · Baylor College Of Medicine$22,055,847
- Randal J. Kaufman · Indiana University Indianapolis$21,677,694
- Richard I. Morimoto · Northwestern University$18,534,805
- William Tobey Wickner · Dartmouth College$17,981,123
Research focus
Molecular ChaperonesApoptosisMitochondriaPhosphorylationStressKidney CellCell DeathMediatingIn VivoRenal IschemiaSiteKidneyInjuryEpithelial CellsProteinsMitochondrial MembraneLifeRenal FunctionBlood FlowNucleophosminIschemiaPeptidesCell SurvivalPrevent
Grant awards (22)
Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury$471,531
R01 · FY2025 · DK · contact PI
Medical Scientist Training Program (MSTP)$233,180
T32 · FY2025 · GM
Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury$506,061
R01 · FY2024 · DK · contact PI
Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury$546,108
R01 · FY2023 · DK · contact PI
Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury$249,200
R01 · FY2021 · DK · contact PI
Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury$249,200
R01 · FY2020 · DK · contact PI
Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury$249,200
R01 · FY2019 · DK · contact PI
Cytoprotective Role of HSP72 in Renal Cell Injury$378,450
R01 · FY2016 · DK · contact PI
Cytoprotective Role of HSP72 in Renal Cell Injury$378,450
R01 · FY2015 · DK · contact PI
Cytoprotective Role of HSP72 in Renal Cell Injury$376,275
R01 · FY2014 · DK · contact PI
Cytoprotective Role of HSP72 in Renal Cell Injury$370,475
R01 · FY2013 · DK · contact PI
Cytoprotective Role of HSP72 in Renal Cell Injury$250,965
R01 · FY2012 · DK · contact PI
Cytoprotective Role of HSP72 in Renal Cell Injury$250,965
R01 · FY2011 · DK · contact PI
Cytoprotective Role of HSP72 in Renal Cell Injury$253,500
R01 · FY2010 · DK · contact PI
CYTOPROTECTIVE ROLE OF HSP72 IN RENAL CELL INJURY$335,067
R01 · FY2007 · DK · contact PI
CYTOPROTECTIVE ROLE OF HSP72 IN RENAL CELL INJURY$345,075
R01 · FY2006 · DK · contact PI
CYTOPROTECTIVE ROLE OF HSP72 IN RENAL CELL INJURY$353,379
R01 · FY2005 · DK
CYTOPROTECTIVE ROLE OF HSP72 IN RENAL CELL INJURY$353,379
R01 · FY2004 · DK
CYTOPROTECTIVE ROLE OF HSP72 IN RENAL CELL INJURY$353,379
R01 · FY2003 · DK
CYTOPROTECTIVE ROLE OF HSP 72 IN RENAL CELL INJURY$361,958
R01 · FY2002 · DK
CYTOPROTECTIVE ROLE OF HSP 72 IN RENAL CELL INJURY$351,415
R01 · FY2001 · DK
CYTOPROTECTIVE ROLE OF HSP 72 IN RENAL CELL INJURY$341,181
R01 · FY2000 · DK